Lyell Immunopharma (LYEL) Profit After Tax: 2020-2025
Historic Profit After Tax for Lyell Immunopharma (LYEL) over the last 6 years, with Sep 2025 value amounting to -$38.8 million.
- Lyell Immunopharma's Profit After Tax rose 12.87% to -$38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$325.7 million, marking a year-over-year decrease of 59.65%. This contributed to the annual value of -$343.0 million for FY2024, which is 46.18% down from last year.
- Latest data reveals that Lyell Immunopharma reported Profit After Tax of -$38.8 million as of Q3 2025, which was up 8.99% from -$42.7 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Profit After Tax ranged from a high of -$8.4 million in Q4 2022 and a low of -$191.9 million during Q4 2024.
- In the last 3 years, Lyell Immunopharma's Profit After Tax had a median value of -$52.2 million in 2025 and averaged -$64.7 million.
- In the last 5 years, Lyell Immunopharma's Profit After Tax surged by 89.97% in 2022 and then plummeted by 530.34% in 2023.
- Lyell Immunopharma's Profit After Tax (Quarterly) stood at -$83.7 million in 2021, then spiked by 89.97% to -$8.4 million in 2022, then slumped by 530.34% to -$52.9 million in 2023, then plummeted by 262.62% to -$191.9 million in 2024, then grew by 12.87% to -$38.8 million in 2025.
- Its Profit After Tax stands at -$38.8 million for Q3 2025, versus -$42.7 million for Q2 2025 and -$52.2 million for Q1 2025.